WeVote
Log In

Bill

Bill

SB 433

MEDICAID: Provides for Medicaid coverage of certain medications. (1/1/27) (EN +$3,000,000 GF EX See Note)

2026 Regular Session Introduced by Regina Barrow and 30 co-sponsors

Louisiana SB 433 requires Medicaid MCOs to cover FDA-approved weight loss meds for eligible adults, with prior authorization, initial six months, and continued coverage if improved

Effective date 6/9/2026.
0
WeVote Research Nonpartisan
Bill Summary · SB 433

Legislative Bill Summary – Louisiana SB 433 (2026 Regular Session)

Title

MEDICAID: Provides for Medicaid coverage of certain medications. (Effective 1/1/2027)

Bill at a Glance

  • Sponsor: Senator Boudreaux (Co-sponsor: Gerald Boudreaux)
  • Jurisdiction: Louisiana
  • Subject: Requires Medicaid coverage for FDA-approved weight loss medications
  • Effective Date: January 1, 2027
  • Fiscal note indicator: OR INCREASE GF EX (implies potential General Fund impact; note: specific fiscal details not provided in the text)

Purpose and Intent

To authorize and require Medicaid managed care organizations (MCOs) in Louisiana to cover FDA-approved weight loss medications for eligible adult recipients, expanding access to pharmacologic weight management under the state’s Medicaid program.

Key Provisions

  1. Coverage Requirement

    • Medicaid MCOs must cover FDA-approved weight loss medications prescribed by a licensed healthcare provider.
    • Eligible recipient: Medicaid beneficiary age 18 or older.

  2. Eligibility Criteria for Coverage
    A. A recipient with:

    • Body Mass Index (BMI) of 30 or higher AND at least one associated comorbidity (examples: type 2 diabetes, prediabetes, hypertension, cardiovascular disease), or B. A recipient with BMI of 35 or higher.

  3. Pre-Authorization

    • Coverage is contingent on prior authorization.
    • Prior authorization is limited to verification that the patient meets the specified eligibility criteria.

  4. Initial and Continued Coverage

    • Initial authorization for coverage shall not exceed six months.
    • For continued coverage beyond six months, there must be documented clinical improvements by the patient’s healthcare provider.

  5. Step Therapy

    • The law prohibits step therapy requirements for coverage of weight loss medications under this provision. (No forced stepwise progression through other treatments before approving the weight loss medication.)

  6. Budgetary and Policy Safeguards

    • The Department of Health (including LDH) and Medicaid MCOs must implement coverage in a manner that is fiscally sustainable and compliant with federal requirements.
    • The bill specifies that there shall be no additional eligibility restrictions beyond those stated in the act.

  7. Effective Date

    • The act becomes effective January 1, 2027.

Who Is Affected

  • Medicaid beneficiaries 18 years of age and older who meet the BMI and comorbidity criteria outlined.
  • Louisiana Department of Health (LDH) and Medicaid managed care organizations that administer Medicaid coverage and prior authorization processes.
  • Licensed healthcare providers prescribing FDA-approved weight loss medications to eligible Medicaid recipients.

Procedural and Timeline Aspects

  • Effective date: January 1, 2027.
  • Coverage and prior authorization processes must align with the criteria and timelines set forth (initial six-month authorization window; continued coverage requires documented clinical improvement).
  • The legislation sets explicit parameters to avoid step therapy and to ensure fiscal sustainability.

Additional Context

  • The bill adds a new statutory subsection: R.S. 46:460.38, establishing the framework for weight loss medication coverage under Medicaid.
  • It emphasizes clinical effectiveness documentation for ongoing coverage and restricts administrative barriers beyond those specified (no extra eligibility hurdles).

If you would like, I can compare SB 433 to current Louisiana Medicaid policies on weight loss medications or provide a quick impact estimate based on potential patient counts and typical drug costs.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.